Ezetimibe contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Ezetimibe}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== ZETIA is contraindicated in the following conditions: *The combination of ZETIA with a statin is contra...")
 
(Redirected page to Ezetimibe)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Ezetimibe]]
{{Ezetimibe}}
{{CMG}}; {{AE}} {{SS}}
 
==Contraindications==
 
ZETIA is contraindicated in the following conditions:
 
*The combination of ZETIA with a statin is contraindicated in patients with active liver disease or unexplained persistent elevations in hepatic transaminase levels.
*Women who are pregnant or may become pregnant. Because [[statins]] decrease cholesterol synthesis and possibly the synthesis of other biologically active substances derived from cholesterol, ZETIA in combination with a statin may cause fetal harm when administered to pregnant women. Additionally, there is no apparent benefit to therapy during pregnancy, and safety in pregnant women has not been established. If the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus and the lack of known clinical benefit with continued use during pregnancy. [See Use in Specific Populations (8.1).]
*Nursing mothers. Because [[statins]] may pass into breast milk, and because [[statins]] have the potential to cause serious adverse reactions in nursing infants, women who require ZETIA treatment in combination with a statin should be advised not to nurse their infants [see Use in Specific Populations (8.3)].
*Patients with a known [[hypersensitivity]] to any component of this product. [[hypersensitivity]] reactions including [[anaphylaxis]], [[angioedema]], [[rash]] and [[urticaria]] have been reported with ZETIA [see Adverse Reactions (6.2)].<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ZETIA (EZETIMIBE) TABLET [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a773b0b2-d31c-4ff4-b9e8-1eb2d3a4d62a | publisher =  | date =  | accessdate = 11 February 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
[[Category:Hypolipidemic agents]]
[[Category:Lactams]]
[[Category:Merck]]
[[Category:Schering-Plough]]
[[Category:Azetidines]]
[[Category:Organofluorides]]
[[Category:Phenols]]
[[Category:Cardiovasuclar Drugs]]
[[Category:Drugs]]

Latest revision as of 14:13, 21 July 2014

Redirect to: